New York Life Investment Management’s Innoviva INVA Stock Holding History

New York Life Investment Management’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-30,697	Closed	-$492K	–	1428
2023 Q4	$492K	Sell	30,697 -902	-3%	-$12.6K	0.01%	849
2023 Q3	$410K	Sell	31,599 -5,035	-14%	-$65.4K	﹤0.01%	851
2023 Q2	$466K	Sell	36,634 -5,735	-14%	-$71.8K	﹤0.01%	776
2023 Q1	$477K	Buy	42,369 +13,053	+45%	+$158K	0.01%	977
2022 Q4	$388K	Buy	29,316 +3,302	+13%	+$43.4K	﹤0.01%	1055
2022 Q3	$302K	Buy	26,014 +1,914	+8%	+$26.2K	﹤0.01%	1103
2022 Q2	$356K	Buy	+24,100	New	+$395K	﹤0.01%	1077

Other funds holding INVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

New York Life Investment Management's INVA Position: Q1 2024 in Review

New York Life Investment Management sold out of Innoviva (INVA) in Q1 2024, closing a stake of 30,697 shares — an estimated $492K sold.

New York Life Investment Management first reported a position in INVA in Q2 2022 and held it in 7 quarters. The position peaked at $492K in Q4 2023. 217 funds tracked by Wall St. Rank hold INVA as of Q1 2024.

New York Life Investment Management reported no remaining Innoviva position as of Q1 2024 after selling out during the quarter.
New York Life Investment Management sold 30,697 Innoviva shares in Q1 2024, an estimated $492K.
New York Life Investment Management first reported a position in Innoviva in Q2 2022 and held it in 7 quarters.
New York Life Investment Management's Innoviva position peaked at $492K in Q4 2023.
217 funds tracked by Wall St. Rank held Innoviva as of Q1 2024.

Based on New York Life Investment Management's 13F filing for Q1 2024, filed 6 May 2024.